Lawrence H Einhorn MD
Professor, Medicine, Indiana University School of Medicine
Join to View Full Profile
535 Barnhill DrRt 473Indianapolis, IN 46202
Phone+1 317-274-3515
Dr. Einhorn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 1972 - 1973
Indiana University School of MedicineResidency, Internal Medicine, 1968 - 1969- Indiana University School of Medicine/Methodist HospitalInternship, Transitional Year, 1967 - 1968
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1967
Certifications & Licensure
CA State Medical License 1971 - Present
IN State Medical License 1971 - 2027
IA State Medical License 1968 - 1988
OH State Medical License 1968 - 1972
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Powerchart, Cerner Healthe and Cerner Patient Portal, Cerner Corporation, 2014
- CMS Meaningful Use Stage 1 Certification FirstNet, Cerner Healthe and Cerner Patient Portal, Cerner Corporation, 2014
- CMS Meaningful Use Stage 1 Certification PowerChart, Cerner Healthe, Cerner Patient Portal, HealthSentry and P2 Sentinel, Cerner Corporation, 2014
Clinical Trials
- Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors Start of enrollment: 1999 Jan 25
- A Phase II Study of Iressa in Patients With Chemo Refractory Germ Cell Tumors Expressing EGFR Start of enrollment: 2002 Sep 01
- Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors Start of enrollment: 2000 Oct 01
Publications & Presentations
PubMed
- SMARCB1/INI1-deficient carcinoma with yolk sac tumor-like features in the inguinal region of a young man: a case of a deceptive and emerging entity.Harini Venkatraman Ravisankar, Lawrence H Einhorn, Thomas M Ulbright
Virchows Archiv. 2026-03-01 - Impact of Population Pharmacogenomics on Cisplatin-Induced Neurotoxicities in Testicular Cancer Survivors.Swetha Nakshatri, Paul C Dinh Jr, Lawrence H Einhorn, Darren R Feldman, Robert J Hamilton
Cancer Medicine. 2025-09-01 - 1 citationsLongitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors.Rebecca Hassoun, Reuben Ben-David, John P Sfakianos, George Laliotis, Cherry Au
JCO Precision Oncology. 2025-09-01
Journal Articles
- Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International CollaborationRichard S Foster, Lawrence H Einhorn, Christopher J Sweeney, Guru Sonpavde, Costantine Albany, Chandra K Flack, The Journal of Urology
Press Mentions
- The Formative Years of Medical Oncology in the United States: A Rough and Tumble Road, Part 2October 10th, 2024
Patients Praise IU Health Physician Known for Testicular Cancer TreatmentApril 25th, 2022
The Importance of Having Mentors, Both Locally and GloballyMarch 11th, 2020
Grant Support
- Core--Prognostic ModelingNational Cancer Institute1999–2001
- Biology Of High Risk Germ Cell NeoplasiaNational Cancer Institute1999–2001
- Clinical Trials In OncologyNational Cancer Institute1994–1998
- Ly213514 (Thymidylate Synthase Inhibitor) With Metastatic Colorectal CancerNational Center For Research Resources1997
- Intrapleural Batimastat With Malignant Pleural EffusionNational Center For Research Resources1997
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
